Published in Proc Natl Acad Sci U S A on September 16, 1997
Genomic imprinting: implications for human disease. Am J Pathol (1999) 2.26
Human hepatocyte carcinogenesis (review). Int J Oncol (2013) 1.28
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies. Proc Natl Acad Sci U S A (2004) 1.11
Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J Cell Biol (1998) 1.09
Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis. Br J Cancer (2003) 1.05
The clonal origin and clonal evolution of epithelial tumours. Int J Exp Pathol (2000) 1.04
Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World J Gastroenterol (2008) 1.04
Tissue-specific inactivation of murine M6P/IGF2R. Am J Pathol (2003) 1.01
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. Am J Pathol (1999) 0.96
Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer (2001) 0.96
Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges. World J Gastroenterol (2007) 0.94
Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes. Proc Natl Acad Sci U S A (1998) 0.94
Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women. Growth Horm IGF Res (2010) 0.92
Genomic imprinting and cancer. Mol Pathol (1998) 0.91
Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan. Br J Cancer (1999) 0.90
Imprinted genes as potential genetic and epigenetic toxicologic targets. Environ Health Perspect (2000) 0.88
Targeting the insulin-like growth factor pathway in hepatocellular carcinoma. World J Hepatol (2014) 0.87
Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells. BMC Cancer (2002) 0.87
The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. J Hepatol (2008) 0.87
Molecular mechanisms underlying hepatocellular carcinoma. Viruses (2009) 0.87
Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer (2011) 0.86
M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis. BMC Cancer (2003) 0.84
Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World J Gastroenterol (2003) 0.82
Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes. BMC Cell Biol (2004) 0.82
Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study. BMC Res Notes (2008) 0.82
Proteinases and their inhibitors in liver cancer. World J Hepatol (2009) 0.81
Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma. PLoS One (2013) 0.79
M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues. J Hepatol (2012) 0.79
IGF2R missense single-nucleotide polymorphisms and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2009) 0.76
Expression of insulin-like growth factor family genes in clear cell renal cell carcinoma. Contemp Oncol (Pozn) (2016) 0.75
Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma. World J Gastroenterol (2008) 0.75
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol (2016) 0.75
The mannose 6-phosphate-binding sites of M6P/IGF2R determine its capacity to suppress matrix invasion by squamous cell carcinoma cells. Biochem J (2013) 0.75
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res (1994) 11.29
Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem (1992) 5.64
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A (1994) 3.76
Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science (1996) 3.54
Insulin-like growth factor II receptor as a multifunctional binding protein. Nature (1987) 3.52
Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med (1981) 3.17
Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol (1996) 2.27
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A (1991) 2.27
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res (1996) 1.80
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
Morphologic studies of the liver cell dysplasia. Cancer (1983) 1.70
Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res (1996) 1.51
M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene (1996) 1.31
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene (1995) 1.22
Imprinted genes in liver carcinogenesis. FASEB J (1997) 1.22
The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res (1997) 1.09
Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodules. Cancer Res (1992) 1.03
Clonal analysis of precancerous lesion of hepatocellular carcinoma. Gastroenterology (1996) 0.96
Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. Gastroenterology (1994) 0.96
Molecular biomarkers for aflatoxins and their application to human cancer prevention. Cancer Res (1994) 0.93
The mouse insulin-like growth factor II/cation-independent mannose 6-phosphate (IGF-II/MPR) receptor gene: molecular cloning and genomic organization. Genomics (1994) 0.92
Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical considerations. Semin Liver Dis (1995) 0.91
Subregional mapping of 8 single copy loci to chromosome 6 by fluorescence in situ hybridization. Cytogenet Cell Genet (1994) 0.88
Frequent microsatellite instability in post hepatitis B viral cirrhosis. Oncogene (1996) 0.85
Improving the polymorphism content of the 3' UTR of the human IGF2R gene. Hum Mol Genet (1992) 0.84
Insulin-like growth factor II/cation-independent mannose 6-phosphate receptor and lysosomal enzyme recognition. Biochem Soc Trans (1996) 0.83
Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys (1995) 3.20
Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res (2000) 2.73
Broca aphasia: pathologic and clinical. Neurology (1978) 2.43
Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension (1995) 2.36
The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz. Med Phys (1994) 2.32
Genomic imprinting: implications for human disease. Am J Pathol (1999) 2.26
Induction kinetics of the L-arabinose operon of Escherichia coli. J Bacteriol (1973) 2.23
The relation between experience and outcome in heart transplantation. N Engl J Med (1992) 2.08
Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93
Fallibility of plasma-digoxin in differentiating toxic from non-toxic patients. Lancet (1971) 1.85
Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res (1982) 1.81
M6P/IGF2R imprinting evolution in mammals. Mol Cell (2000) 1.77
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys (1998) 1.65
Acute childhood leukaemia in relation to the HL-A human transplantation genes. Nature (1970) 1.51
Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med (1993) 1.45
Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood (1972) 1.45
Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg (1995) 1.40
Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology (1995) 1.38
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys (2001) 1.38
Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet (2001) 1.32
M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene (1996) 1.31
Monotreme IGF2 expression and ancestral origin of genomic imprinting. J Exp Zool (2001) 1.28
Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res (1990) 1.27
A questionnaire for the assessment of patients' impressions of the risks and benefits of home telecare. J Telemed Telecare (2000) 1.27
Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med (1993) 1.24
The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2. Genomics (2001) 1.24
Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer (1999) 1.23
Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation. Cancer Res (1981) 1.22
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene (1995) 1.22
Imprinted genes in liver carcinogenesis. FASEB J (1997) 1.22
Bacterial infection promotes DNA hypermethylation. J Dent Res (2007) 1.22
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys (2001) 1.21
Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys (1997) 1.20
Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys (1994) 1.19
Theoretical and measured electric field distributions within an annular phased array: consideration of source antennas. IEEE Trans Biomed Eng (1993) 1.17
Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer (1993) 1.16
Epigenetic detection of human chromosome 14 uniparental disomy. Hum Mutat (2003) 1.15
M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene (2000) 1.14
Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst (1982) 1.12
Marsupials and Eutherians reunited: genetic evidence for the Theria hypothesis of mammalian evolution. Mamm Genome (2001) 1.09
Change of patients' perceptions of TeleHomeCare. Telemed J E Health (2001) 1.09
Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers. Am J Pathol (2001) 1.06
JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry. Transplantation (2001) 1.06
Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) (2013) 1.05
Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer (1996) 1.04
Morphologic and histochemical analysis of hepatocytes transplanted into syngeneic hosts. Am J Pathol (1980) 1.03
Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology (1994) 1.02
The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer (1998) 1.01
Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. J Biol Chem (1999) 1.01
Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol (2001) 1.00
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg (1995) 1.00
p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis. Am J Surg Pathol (1997) 0.99
Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats. Cancer Res (1982) 0.99
Complete spontaneous regression of pulmonary metastatic melanoma. Dermatol Surg (1998) 0.99
Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Oncogene (1998) 0.99
Managing professional intellect: making the most of the best. Harv Bus Rev (1996) 0.99
K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett (1997) 0.98
Microwave power absorption differences between normal and malignant tissue. Int J Radiat Oncol Biol Phys (1980) 0.98
Imprint status of M6P/IGF2R and IGF2 in chickens. Dev Genes Evol (2001) 0.98
Repair of radiation damage in noncycling parenchymal hepatocytes. Br J Radiol (1982) 0.96
Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine. Cancer Res (1984) 0.96
Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res (1995) 0.96
Rapamycin blocks sexual development in fission yeast through inhibition of the cellular function of an FKBP12 homolog. J Biol Chem (2001) 0.95
Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut (2004) 0.94
Establishment of two rat hepatoma cell strains produced by a carcinogen initiation, phenobarbital promotion protocol. In Vitro (1983) 0.93
Effects of partial hepatectomy on transplanted hepatocytes. Cancer Res (1982) 0.93
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Cancer Res (1999) 0.92
Sexual experience of the chronic peritoneal dialysis patient. J Am Soc Nephrol (1996) 0.92
Effects of EGF and calcium on adult parenchymal hepatocyte proliferation. J Cell Physiol (1987) 0.90
Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators. Cancer Res (1984) 0.90
Imprinting of PEG3, the human homologue of a mouse gene involved in nurturing behavior. Genomics (2001) 0.90
Angiolymphoid hyperplasia with eosinophilia: a bone lesion pathologically resembling Kimura's disease of skin. A report of two cases. Clin Orthop Relat Res (1982) 0.90
Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology (2001) 0.90
Exclusion of maternal uniparental disomy of chromosome 14 in patients referred for Prader-Willi syndrome using a multiplex methylation polymerase chain reaction assay. J Med Genet (2003) 0.88
Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease. Am J Surg Pathol (1998) 0.88
Imprinted genes as potential genetic and epigenetic toxicologic targets. Environ Health Perspect (2000) 0.88
A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetrance. Gut (2005) 0.87
Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Hum Mutat (2001) 0.86
Polymorphisms, genomic imprinting and cancer susceptibility. Mutat Res (1999) 0.86
Short communication: normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGF beta. Br J Radiol (1995) 0.86
Human hepatocyte-mediated mutagenesis and DNA repair activity. Carcinogenesis (1983) 0.86
Distribution of anionic sites on the capillary endothelium in an experimental brain tumor model. Microcirc Endothelium Lymphatics (1988) 0.85
The influence of in situ repair systems on survival of several irradiated parenchymal cell types. Br J Cancer Suppl (1984) 0.85
Facilitators and barriers to adherence with home monitoring using electronic spirometry. AACN Clin Issues (2001) 0.84
Intracolonic WR 2721 protection of the rat colon from acute radiation injury. Gastroenterology (1986) 0.84
Down-regulation of transforming growth factor beta receptor type I, II, and III during liver regeneration. Am J Surg (1995) 0.84
The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene. Oncogene (1997) 0.84
No relation between HL-A and juvenile diabetes. Tissue Antigens (1972) 0.82
Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer. Prostate Cancer Prostatic Dis (2006) 0.81
Clonidine patch ingestion in an adult. Ann Pharmacother (1993) 0.81
p53 protein expression and gene mutation in phyllodes tumors of the breast. Pathol Res Pract (2001) 0.81
Radiation sensitivity of adult human parenchymal hepatocytes. Radiat Res (1988) 0.81
Altered heterogeneity of monocytes in acute myelomonocytic leukemia. J Natl Cancer Inst (1983) 0.81
Blood flow to lymphatic metastases in conscious rats. Eur J Cancer (1981) 0.80
Cross-species clues of an epigenetic imprinting regulatory code for the IGF2R gene. Cytogenet Genome Res (2006) 0.80
The survival of parenchymal hepatocytes irradiated with low and high LET radiation. Br J Cancer Suppl (1984) 0.80